KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Receivables (2016 - 2025)

Historic Receivables for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $892.8 million.

  • Edwards Lifesciences' Receivables rose 1001.85% to $892.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $892.8 million, marking a year-over-year increase of 1001.85%. This contributed to the annual value of $727.4 million for FY2024, which is 1270.85% down from last year.
  • Edwards Lifesciences' Receivables amounted to $892.8 million in Q3 2025, which was up 1001.85% from $902.6 million recorded in Q2 2025.
  • Edwards Lifesciences' Receivables' 5-year high stood at $902.6 million during Q2 2025, with a 5-year trough of $661.4 million in Q3 2022.
  • Over the past 5 years, Edwards Lifesciences' median Receivables value was $751.9 million (recorded in 2025), while the average stood at $760.2 million.
  • Per our database at Business Quant, Edwards Lifesciences' Receivables soared by 2331.4% in 2021 and then crashed by 1425.48% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Receivables (Quarter) stood at $664.9 million in 2021, then rose by 5.14% to $699.1 million in 2022, then grew by 18.45% to $828.1 million in 2023, then fell by 12.16% to $727.4 million in 2024, then increased by 22.74% to $892.8 million in 2025.
  • Its Receivables was $892.8 million in Q3 2025, compared to $902.6 million in Q2 2025 and $751.9 million in Q1 2025.